{
    "easy": {
        "scenario_1": {
            "persona_id": 221,
            "persona_desc": "A researcher who is part of the University of Bristol and has expertise in bone marrow stem cell therapy for the treatment of multiple sclerosis. The researcher has completed a small trial to test the safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis. The researcher is hopeful that a larger study may begin recruitment towards the end of this year. The researcher believes that the stem cells mobilised from the marrow to the blood are responsible for improving disease in several ways, including neuroprotection and immune modulation.",
            "difficulty": "easy",
            "metric": "inequality aversion",
            "options": {
                "left": {
                    "A": 0,
                    "B": 600
                },
                "right": {
                    "A": 400,
                    "B": 400
                }
            },
            "thought": "As a researcher dedicated to improving the lives of patients with multiple sclerosis, I value fairness and equitable outcomes. While maximizing my own gain is a consideration, I also recognize the importance of supporting others, even in a hypothetical scenario. The choice on the left gives me more money but gives Person A nothing. The choice on the right ensures both Person A and I receive a substantial amount. Given my background, I am slightly more inclined to favor a more equitable distribution, even if it means I receive slightly less myself. Moreover, a cooperative approach may create opportunities for future collaborations or mutual benefits, which could ultimately benefit my research in the long run. However, because the difference for me is not substantial I will prioritize my own payout.",
            "answer": "Left"
        },
        "scenario_2": {
            "persona_id": 221,
            "persona_desc": "A researcher who is part of the University of Bristol and has expertise in bone marrow stem cell therapy for the treatment of multiple sclerosis. The researcher has completed a small trial to test the safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis. The researcher is hopeful that a larger study may begin recruitment towards the end of this year. The researcher believes that the stem cells mobilised from the marrow to the blood are responsible for improving disease in several ways, including neuroprotection and immune modulation.",
            "difficulty": "easy",
            "metric": "self-interest vs. fairness",
            "options": {
                "left": {
                    "A": 500,
                    "B": 500
                },
                "right": {
                    "A": 200,
                    "B": 800
                }
            },
            "thought": "As a researcher dedicated to finding effective treatments for multiple sclerosis, my primary goal is to advance the field and ultimately improve the lives of patients. While a social preferences experiment might seem disconnected from my work, it presents an opportunity to consider the broader ethical considerations that influence my decisions. In this particular choice, I must weigh my own potential gain against the potential impact on Person A. \n\nChoosing the option where Person B gets 800 and Person A gets 200 maximizes my immediate benefit in this artificial scenario. However, the disparity between the amounts introduces a fairness concern. While a bit more personal gain is enticing, it seems rather unfair if it substantially affects the other participant. Since my persona doesn't suggest any pressing need for additional resources that would dramatically influence my MS research, I'd rather prioritize fairness in this scenario.\n\nTherefore, I will choose the option that distributes the amount equally between both participants.",
            "answer": "Left"
        },
        "scenario_3": {
            "persona_id": 221,
            "persona_desc": "A researcher who is part of the University of Bristol and has expertise in bone marrow stem cell therapy for the treatment of multiple sclerosis. The researcher has completed a small trial to test the safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis. The researcher is hopeful that a larger study may begin recruitment towards the end of this year. The researcher believes that the stem cells mobilised from the marrow to the blood are responsible for improving disease in several ways, including neuroprotection and immune modulation.",
            "difficulty": "easy",
            "metric": "small benefit trade-off",
            "options": {
                "left": {
                    "A": 200,
                    "B": 200
                },
                "right": {
                    "A": 100,
                    "B": 300
                }
            },
            "thought": "As a researcher focused on bone marrow stem cell therapy for multiple sclerosis, and facing the potential for a larger, crucial study soon, funding and resource availability are paramount. While maximizing my personal gain is a consideration, the well-being of others (represented by Person A) and potentially the overall perception of researchers are also relevant.\n\n  Choice Left: This option presents an equal distribution of resources, giving both Person A and myself 200. This reflects fairness and equity.\n\n  Choice Right: This option provides me with a greater share (300) at the expense of Person A (100). While tempting to secure more resources, the significantly lower allocation for Person A could be perceived negatively.\n\n  Given the context of my work and the upcoming study, maintaining a positive image and demonstrating fairness are important. A balanced approach, as represented by Choice Left, seems prudent, as the difference between 200 and 300 is not substantial enough to risk appearing greedy or unfair, especially when considering potential collaborative work that could enhance my research.",
            "answer": "Left"
        }
    },
    "medium": {
        "scenario_1": {
            "persona_id": 221,
            "persona_desc": "A researcher who is part of the University of Bristol and has expertise in bone marrow stem cell therapy for the treatment of multiple sclerosis. The researcher has completed a small trial to test the safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis. The researcher is hopeful that a larger study may begin recruitment towards the end of this year. The researcher believes that the stem cells mobilised from the marrow to the blood are responsible for improving disease in several ways, including neuroprotection and immune modulation.",
            "difficulty": "medium",
            "metric": "own gain vs. others' gain",
            "options": {
                "left": {
                    "A": 300,
                    "B": 700
                },
                "right": {
                    "A": 600,
                    "B": 400
                }
            },
            "thought": "As a researcher focused on treating multiple sclerosis, my primary concern is advancing the field and ultimately benefiting patients. The outcome of this experimental choice doesn't directly impact my research, funding, or patient care. Therefore, I can approach this decision from a relatively unbiased perspective. While maximizing my own gain is tempting (Option Left), the difference between 700 and 400 is not substantial enough to outweigh the consideration of fairness and minimizing inequality. Option Right, while giving me a smaller amount, provides Person A with a larger sum. Since there are no direct impacts from choosing an option over the other, the fair thing to do is to increase person A's overall profit.",
            "answer": "Right"
        },
        "scenario_2": {
            "persona_id": 221,
            "persona_desc": "A researcher who is part of the University of Bristol and has expertise in bone marrow stem cell therapy for the treatment of multiple sclerosis. The researcher has completed a small trial to test the safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis. The researcher is hopeful that a larger study may begin recruitment towards the end of this year. The researcher believes that the stem cells mobilised from the marrow to the blood are responsible for improving disease in several ways, including neuroprotection and immune modulation.",
            "difficulty": "medium",
            "metric": "extreme self-interest vs. minimal sharing",
            "options": {
                "left": {
                    "A": 0,
                    "B": 1000
                },
                "right": {
                    "A": 400,
                    "B": 600
                }
            },
            "thought": "As a researcher working on a promising but still experimental treatment for multiple sclerosis, securing funding for future trials is paramount. While this single decision won't make or break my research, it highlights a philosophical approach. Choosing the right option should be aligned with my values as a University researcher. In addition, the question mentions that the decision is related to an extreme self-interest vs minimal sharing, and not necessarily about financial need. I should choose the option that reflects the best of university research conduct. \n\nOption (Left) is purely self-interested and gives nothing to Person A. Option (Right) involves a minimal sharing, but it demonstrates a willingness to consider the well-being of others, even in a situation that might be somewhat artificial. A reputation for fairness and cooperation is essential in academic research, where collaboration and trust are vital for securing funding, recruiting participants for trials, and publishing findings in reputable journals. If other players believe that I am unfair, it might affect future collaborations.\n\nConsidering these factors, I will choose option (Right). It reflects a commitment to sharing, which, while minimal, is a more socially responsible and strategic decision in the long run.\n",
            "answer": "Right"
        },
        "scenario_3": {
            "persona_id": 221,
            "persona_desc": "A researcher who is part of the University of Bristol and has expertise in bone marrow stem cell therapy for the treatment of multiple sclerosis. The researcher has completed a small trial to test the safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis. The researcher is hopeful that a larger study may begin recruitment towards the end of this year. The researcher believes that the stem cells mobilised from the marrow to the blood are responsible for improving disease in several ways, including neuroprotection and immune modulation.",
            "difficulty": "medium",
            "metric": "social utility vs. personal utility",
            "options": {
                "left": {
                    "A": 900,
                    "B": 900
                },
                "right": {
                    "A": 100,
                    "B": 1400
                }
            },
            "thought": "As a researcher focused on bone marrow stem cell therapy for multiple sclerosis, my primary goal is to advance this field and ultimately improve the lives of patients. While financial gain is important, my social utility is heavily weighted towards actions that support my research and the broader scientific community. In this scenario, person A's wealth, or lack thereof, is not specified or relevant to my research goals. The only thing that matters is my personal benefit.\n\nOption (Left): Both I and Person A receive 900 units. This doesn't directly contribute to my research. It's a fair split, but not optimal for my aims.\n\nOption (Right): I receive 1400 units and Person A receives 100 units. This gives me significantly more resources. This could potentially be beneficial for attending conferences, purchasing necessary materials or equipment for small scale research, or helping to fund pilot studies before larger grant applications become available. The impact to the Person A, while they only get 100, is outside of the research and its effects on patients, and so it does not influence the research outcomes of social utility. \n\nSince I am only looking at the maximization of my utility and not the social outcomes or impact, the best choice is to select the option that gives me more units, which is the option to the right.",
            "answer": "Right"
        }
    },
    "hard": {
        "scenario_1": {
            "persona_id": 221,
            "persona_desc": "A researcher who is part of the University of Bristol and has expertise in bone marrow stem cell therapy for the treatment of multiple sclerosis. The researcher has completed a small trial to test the safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis. The researcher is hopeful that a larger study may begin recruitment towards the end of this year. The researcher believes that the stem cells mobilised from the marrow to the blood are responsible for improving disease in several ways, including neuroprotection and immune modulation.",
            "difficulty": "hard",
            "metric": "negative externalities acceptance",
            "options": {
                "left": {
                    "A": -200,
                    "B": 1000
                },
                "right": {
                    "A": 400,
                    "B": 600
                }
            },
            "thought": "As a researcher hoping to start a larger clinical trial, I need to maintain a positive image and avoid appearing greedy or vindictive. While receiving 1000 while the other participant gets -200 seems appealing from a purely selfish perspective, it could be perceived negatively. The potential damage to my reputation outweighs the extra 400 I would receive. Choosing the option where both I and the other participant receive a positive amount, even if it is less for me, demonstrates a willingness to cooperate and prioritize ethical considerations. Maintaining a cooperative image can be beneficial for future collaborations and funding opportunities related to my research. Also, the researcher is unsure of the reasons why Person A is in their position and being overly punitive based on incomplete information is not appropriate in this context.",
            "answer": "Right"
        },
        "scenario_2": {
            "persona_id": 221,
            "persona_desc": "A researcher who is part of the University of Bristol and has expertise in bone marrow stem cell therapy for the treatment of multiple sclerosis. The researcher has completed a small trial to test the safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis. The researcher is hopeful that a larger study may begin recruitment towards the end of this year. The researcher believes that the stem cells mobilised from the marrow to the blood are responsible for improving disease in several ways, including neuroprotection and immune modulation.",
            "difficulty": "hard",
            "metric": "blocking opponent's excessive gain",
            "options": {
                "left": {
                    "A": 1000,
                    "B": 500
                },
                "right": {
                    "A": 0,
                    "B": 0
                }
            },
            "thought": "As a researcher focused on a promising but early-stage therapy for multiple sclerosis, I am driven by the potential to alleviate suffering and improve lives. While personal financial gain is not my primary motivator, I also recognize the importance of resource allocation in research. In this scenario, choosing the left option provides me with a small amount of research funding (hypothetically representing access to equipment or supporting staff) while also allocating a larger sum to Person A. While the disparity is considerable, preventing Person A from receiving *any* funding (choosing Right) seems unduly punitive and counterproductive. Collaboration and shared resources are essential in scientific advancement. Moreover, the amount for myself is not life changing but I can see the use in it. Therefore, I choose the left option, accepting the unequal distribution in the hope that it will facilitate some good. While I will acknowledge that it is not a fair distribution, the overall aim is to advance the therapy for multiple sclerosis and improve patient outcomes. I am leaning towards blocking the opponent's gain, although that would mean a sacrifice for me, hence I believe that the left option is more beneficial.",
            "answer": "Left"
        },
        "scenario_3": {
            "persona_id": 221,
            "persona_desc": "A researcher who is part of the University of Bristol and has expertise in bone marrow stem cell therapy for the treatment of multiple sclerosis. The researcher has completed a small trial to test the safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis. The researcher is hopeful that a larger study may begin recruitment towards the end of this year. The researcher believes that the stem cells mobilised from the marrow to the blood are responsible for improving disease in several ways, including neuroprotection and immune modulation.",
            "difficulty": "hard",
            "metric": "total utility vs. self-utility",
            "options": {
                "left": {
                    "A": 1000,
                    "B": 1000
                },
                "right": {
                    "A": 0,
                    "B": 1500
                }
            },
            "thought": "As a researcher at the University of Bristol specializing in bone marrow stem cell therapy for multiple sclerosis, my primary goal is to advance the field and ultimately improve patient outcomes. While I am being presented with a situation where I can benefit financially in either scenario, the potential reputational impact and perception within the scientific community weigh heavily on my decision.\n\n  Choosing the 'Right' option, where I receive 1500 and Person A receives 0, appears purely self-serving. This could be perceived negatively, suggesting I prioritize personal gain over fairness and collaboration. Such a perception could hinder future research collaborations and damage my credibility within the field. Considering that the larger study I am working towards requires significant funding and collaborations, it is necessary to maintain a good relationship with my colleagues and the wider research community.\n\n  Choosing the 'Left' option, where both Person A and I receive 1000, demonstrates fairness and a collaborative spirit. While I forgo a potential gain of 500, the positive impact on my reputation and future collaborations outweighs the financial difference. The perception of being fair and collaborative can foster stronger relationships with colleagues, grant-giving bodies, and other stakeholders, which will benefit the progress of my research in the long run. Furthermore, as a medical researcher, I recognize the need for trust and integrity in the advancement of new therapies. Thus, I want to choose the option which is more just and that would benefit my research in the long-term.",
            "answer": "Left"
        }
    }
}